Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics

Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics

Casein Kinase 2 (CSNK2) is an extremely pleiotropic, ubiquitously expressed protein kinase involved in the regulation of numerous key biological processes. Mapping the CSNK2-dependent phosphoproteome is necessary for better characterization of its fundamental role in cellular signalling. While ATP-c...

Full description

Bibliographic Details
Main Authors:	Laszlo Gyenis, Daniel Menyhart, Edward S. Cruise, Kristina Jurcic, Scott E. Roffey, Darren B. Chai, Flaviu Trifoi, Sam R. Fess, Paul J. Desormeaux, Teresa Núñez de Villavicencio Díaz, Adam J. Rabalski, Stephanie A. Zukowski, Jacob P. Turowec, Paula Pittock, Gilles Lajoie, David W. Litchfield
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Molecular Biosciences
Subjects:	protein kinase CK2 CSNK2 chemical genetics CX-4945 phosphoproteomics SILAC
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2022.909711/full

Similar Items

Phosphoproteomic mapping of CCR5 and ACKR2 signaling properties
by: Alessandro Vacchini, et al.
Published: (2022-11-01)

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945
by: Mauro Rosales, et al.
Published: (2021-02-01)

Differential Modulation of the Phosphoproteome by the MAP Kinases Isoforms p38α and p38β
by: Dganit Melamed Kadosh, et al.
Published: (2023-08-01)

In Skeletal Muscle Fibers, Protein Kinase Subunit CSNK2A1/CK2α Is Required for Proper Muscle Homeostasis and Structure and Function of Neuromuscular Junctions
by: Mira Merholz, et al.
Published: (2022-12-01)

CK2 Regulation: Perspectives in 2021
by: Scott E. Roffey, et al.
Published: (2021-09-01)

RETREG3/FAM134C phosphorylation by CSNK2 regulates reticulophagy during starvation
by: Giorgia Di Lorenzo, et al.
Published: (2022-12-01)

SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells
by: Young Eun Kim, et al.
Published: (2021-02-01)

Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia
by: Maria Hernandez-Valladares, et al.
Published: (2016-08-01)

Phenolization vs SILaC Laser: Which is More Successful in the Treatment of Pilonidal Sinus Disease?
by: Ömer Yalkın, et al.
Published: (2022-09-01)

CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway
by: Shuang Yang, et al.
Published: (2023-09-01)

Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2
by: Satoru Torii, et al.
Published: (2023-09-01)

New RoxS sRNA Targets Identified in Bacillus subtilis by Pulsed SILAC
by: Delphine Allouche, et al.
Published: (2023-08-01)

CSNK2A1‐mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer
by: Zhan Shi, et al.
Published: (2021-08-01)

SILAC-based quantitative proteomic analysis of Drosophila gastrula stage embryos mutant for fibroblast growth factor signalling
by: Hamze Beati, et al.
Published: (2020-10-01)

Modeling SILAC Data to Assess Protein Turnover in a Cellular Model of Diabetic Nephropathy
by: Barbara Di Camillo, et al.
Published: (2023-02-01)

Age-dependent changes in protein incorporation into collagen-rich tissues of mice by in vivo pulsed SILAC labelling
by: Yoanna Ariosa-Morejon, et al.
Published: (2021-09-01)

Measuring pathway database coverage of the phosphoproteome
by: Hannah Huckstep, et al.
Published: (2021-05-01)

Splicing Interruption by Intron Variants in CSNK2B Causes Poirier–Bienvenu Neurodevelopmental Syndrome: A Focus on Genotype–Phenotype Correlations
by: Wen Zhang, et al.
Published: (2022-06-01)

Synthesis of 5-Benzylamino and 5-Alkylamino-Substituted Pyrimido[4,5-c]quinoline Derivatives as CSNK2A Inhibitors with Antiviral Activity
by: Kesatebrhan Haile Asressu, et al.
Published: (2024-02-01)

CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
by: Usama Khamis Hussein, et al.
Published: (2021-07-01)

Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complex
by: Li Gu, et al.
Published: (2023-06-01)

Loss of Protein Kinase Csnk2b/CK2β at Neuromuscular Junctions Affects Morphology and Dynamics of Aggregated Nicotinic Acetylcholine Receptors, Neuromuscular Transmission, and Synaptic Gene Expression
by: Nane Eiber, et al.
Published: (2019-08-01)

Pulsed SILAC-based proteomic analysis unveils hypoxia- and serum starvation-induced de novo protein synthesis with PHD finger protein 14 (PHF14) as a hypoxia sensitive epigenetic regulator in cell cycle progression
by: Park, Jung Eun, et al.
Published: (2020)

Insights into the Lysine Acetylome of the Haloarchaeon <i>Haloferax volcanii</i> during Oxidative Stress by Quantitative SILAC-Based Proteomics
by: Ricardo L. Couto-Rodríguez, et al.
Published: (2023-06-01)

Circadian gene CSNK1D promoted the progression of hepatocellular carcinoma by activating Wnt/β-catenin pathway via stabilizing Dishevelled Segment Polarity Protein 3
by: Mengqi Zhu, et al.
Published: (2022-12-01)

Phylogenetic relationship based on flavonoids and its regions studies on selected Boesenbergia species in Sabah
by: Lam, Nyee Fan
Published: (2004)

Ecological studies on the nepenthes species along Kaingaran Trail of Mount Trus Madi, Sabah, Malaysia
by: Alviana Damit
Published: (2019)

Phosphoproteome Discovery in Human Biological Fluids
by: Francesco Giorgianni, et al.
Published: (2016-12-01)

Dynamic proteomic and phosphoproteomic atlas of corticostriatal axons in neurodevelopment
by: Vasin Dumrongprechachan, et al.
Published: (2022-10-01)

Integrative proteomic and phosphoproteomic analysis in the female goat hypothalamus to study the onset of puberty
by: Jing Ye, et al.
Published: (2023-10-01)

Phosphorylation-Mediated Molecular Pathway Changes in Human Pituitary Neuroendocrine Tumors Identified by Quantitative Phosphoproteomics
by: Jiajia Li, et al.
Published: (2021-08-01)

Quantitative Analysis of the Cardiac Phosphoproteome in Response to Acute β-Adrenergic Receptor Stimulation In Vivo
by: Alican Güran, et al.
Published: (2021-11-01)

Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H
by: Miaomiao Tian, et al.
Published: (2015-02-01)

CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer
by: Elisabetta Sauta, et al.
Published: (2021-07-01)

Elucidating essential kinases of endothelin signalling by logic modelling of phosphoproteomics data
by: Alexander Schäfer, et al.
Published: (2019-08-01)

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
by: Xiaoyi Chen, et al.
Published: (2023-03-01)

Determination of the Role of Microcystis aeruginosa in Toxin Generation Based on Phosphoproteomic Profiles
by: Jiangqi Qu, et al.
Published: (2018-07-01)

Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model
by: Ang Luo, et al.
Published: (2023-06-01)

Phosphoproteome profiling of mouse liver during normal aging
by: Jiang-Feng Liu, et al.
Published: (2022-08-01)

A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance
by: Luis Vergara-Gómez, et al.
Published: (2023-04-01)